FSLR
47
3
BIIB
42
-2
CVX
32
3
HCP
47
-2
LOW
65
3
SO
68
2
WFC
82
2
UNM
74
2
VIX
38
-8
ICE
55
2
COST
53
-3
RSG
70
2
EXR
46
2
AIZ
64
7
AN
49
3
BEN
48
3
ADM
30
2
O
50
2
MCD
65
2
SJM
28
-8
FSLR
47
3
BIIB
42
-2
CVX
32
3
HCP
47
-2
LOW
65
3
SO
68
2
WFC
82
2
UNM
74
2
VIX
38
-8
ICE
55
2
COST
53
-3
RSG
70
2
EXR
46
2
AIZ
64
7
AN
49
3
BEN
48
3
ADM
30
2
O
50
2
MCD
65
2
SJM
28
-8
Financhill
Back

Kymera Therapeutics Stock Predictions

Urgent: The Biggest Gold Bull Market in History Is Here

Click here for urgent details - don't miss out.
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.27
Seasonality Move:
65.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Don't put a penny in AI stocks until you read this

Discover this under-the-radar AI stock now, ahead of the crowd.

Kymera Therapeutics Stock Forecast

  • Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 54.1% based on the past 4 years of stock performance.
  • Kymera Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Kymera Therapeutics Stock Undervalued?
    The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Kymera Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 54.1% based on the past 4 years of stock performance.

Kymera Therapeutics Stock Rating

Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics overpriced?

  • Kymera Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Kymera Therapeutics Stock Price History

Is KYMR stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kymeratx.com

52-Week Data

52-Week High:
53.27
52-Week Low:
9.60

Prediction Charts

Market Cap:
3.03B
Price in USD:
49.02
Volume:
339.81K
Beta:
2.19

Technical Analysis

SMA50:
46.11
SMA100:
41.39
SMA200:
38.62
52-Wk Change:
286.9%

Stock Predictions

  • Is Kymera Therapeutics stock public?
    Yes, Kymera Therapeutics is a publicly traded company.
  • What is the Kymera Therapeutics stock quote today?
    The Kymera Therapeutics stock price is 49.02 USD today.
  • How to buy Kymera Therapeutics stock online?
    You can buy Kymera Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Sep-27 49.84 48.69 50.60 48.33
Sep-30 48.38 47.27 49.66 46.78
Oct-1 46.96 46.57 47.48 46.02
Oct-2 45.93 45.00 46.25 44.75
Oct-3 44.75 43.43 45.32 43.00
Oct-4 44.07 43.06 44.19 42.71
Oct-7 42.80 42.21 42.94 41.61
Oct-8 42.50 42.97 43.90 42.41
Oct-9 43.25 43.34 43.44 42.00
Oct-10 42.61 43.21 43.93 42.36
Oct-11 43.18 45.02 45.29 43.18
Oct-14 44.74 46.05 46.50 44.74
Oct-15 46.43 44.80 46.43 44.35
Oct-16 45.10 49.02 49.17 44.66

Kymera Therapeutics Earnings

Kymera Therapeutics Earnings Report: Per Share Kymera Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Kymera Therapeutics Forecast Revenue Growth

Kymera Therapeutics Stock Analysis: Historical quarterly revenues per share for Kymera Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.